ArticleScientific reports2025
Glucosamine mitigates hyperglycemic-induced oxidative stress via the SIRT1 pathway in human corneal epithelial cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Persistent loss of membrane-associated MUC4 reprograms physiological functions in corneal epithelial cells via MAPK-dependent cascade.Scientific reports · 2026Article
- ELF3 promotes hyperglycemia-induced corneal epithelial senescence and IL-2 attenuates ELF3-associated signaling.Frontiers in molecular biosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Hyperglycemia threatens vision via inducing irreversible morphologic and physiologic changes in the corneal epithelium. We aimed to investigate whether glucosamine (GlcN) is capable of countering the detrimental effects of high glucose (HG) levels on human corneal epithelial (HCE-T) cells. GlcN failed to attenuate the HG-associated cytotoxicity in HCE-T cells owing to its inherent cytotoxicity. Compared with the decrease in the pAKT/AKT and p-p38/p38 ratios, GlcN induced the KLF4 (Krüppel-like factor 4) and SIRT1 (Sirtuin-1) proteins. Furthermore, GlcN mitigated hyperglycemic-induced reactive oxygen species (ROS) and cellular senescence, and elevated the population of cells in the subG1 and S phases but reduced the population in the G1 phase. Hyperglycemia-induced KLF4 proteins and SIRT1 and fibronectin proteins were enhanced and suppressed by 10 mM GlcN, respectively. GlcN induced the expression of the tight junction protein claudin-1, which was otherwise suppressed in hyperglycemic conditions. Lastly, two SIRT1 inhibitors Ex-527 and INZ mitigated GlcN-induced claudin-1 expression and suppression of hyperglycemic-induced ROS generation. Our study may provide valuable insights into developing therapeutic strategies that utilize GlcN to rejuvenate the corneal epithelium in patients experiencing oxidative and senescent stresses due to poor glycemic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.